19
Actavis Inc, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is DOXYCYCLINE HYCLATE, with a corresponding application number 90134.
Regulatory Information RX
With a dosage strength EQ 50MG BASE
Dosage Form Route TABLET, DELAYED RELEASE; ORAL
Reference Listed Drug No
Approved since 2018-05-22
Therapeutic Equivalence (TE) Code AB
18
Actavis Inc, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is DOXYCYCLINE HYCLATE, with a corresponding application number 90134.
Regulatory Information RX
With a dosage strength EQ 75MG BASE
Dosage Form Route TABLET, DELAYED RELEASE; ORAL
Reference Listed Drug No
Approved since 2011-12-14
Therapeutic Equivalence (TE) Code AB
17
Actavis Inc, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is DOXYCYCLINE HYCLATE, with a corresponding application number 90134.
Regulatory Information RX
With a dosage strength EQ 200MG BASE
Dosage Form Route TABLET, DELAYED RELEASE; ORAL
Reference Listed Drug No
Approved since 2018-05-22
Therapeutic Equivalence (TE) Code AB
16
Actavis Inc, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is DOXYCYCLINE HYCLATE, with a corresponding application number 90134.
Regulatory Information RX
With a dosage strength EQ 100MG BASE
Dosage Form Route TABLET, DELAYED RELEASE; ORAL
Reference Listed Drug No
Approved since 2011-12-14
Therapeutic Equivalence (TE) Code AB